This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ringwald, P.
Right arrow Articles by Basco, L. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ringwald, P.
Right arrow Articles by Basco, L. K.

 Previous Article  |  Next Article 

Antimicrob. Agents Chemother., Oct 1997, 2317-2319, Vol 41, No. 10
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Pyronaridine for treatment of Plasmodium ovale and Plasmodium malariae infections

P Ringwald, J Bickii, A Same-Ekobo and LK Basco
Institut Francais de Recherche Scientifique pour le Developpement en Cooperation (ORSTOM), Organisation de Coordination pour la lutte contre les Endemies en Afrique Centrale, Yaounde, Cameroon.

The clinical efficacy of oral pyronaridine was assessed in 22 symptomatic Cameroonian patients infected with Plasmodium ovale or Plasmodium malariae. All patients were cured on or before day 4. In vitro drug assays confirmed the sensitivity of P. ovale and P. malariae isolates to chloroquine and pyronaridine.


This article has been cited by other articles:

  • Borrmann, S., Szlezak, N., Binder, R. K., Missinou, M. A., Lell, B., Kremsner, P. G. (2002). Evidence for the efficacy of artesunate in asymptomatic Plasmodium malariae infections. J Antimicrob Chemother 50: 751-754 [Abstract] [Full Text]